Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy | Zendy

Chelsea C. Pinnix | Zendy; Jillian R. Gunther | Zendy; Penny Fang | Zendy; Mikaela E. Bankston | Zendy; Sarah A. Milgrom | Zendy; David Boyce-Fappiano | Zendy; Hun Ju Lee | Zendy; Ranjit Nair | Zendy; Raphaël Steiner | Zendy; Paolo Strati | Zendy; Sairah Ahmed | Zendy; Swaminathan P. Iyer | Zendy; Jason R. Westin | Zendy; Simrit Parmar | Zendy; Maria Alma Rodriguez | Zendy; Loretta J. Nastoupil | Zendy; Sattva S. Neelapu | Zendy; Christopher R. Flowers | Zendy; Bouthaina S. Dabaja | Zendy

Open Access

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

Author(s) -

Chelsea C. Pinnix,

Jillian R. Gunther,

Penny Fang,

Mikaela E. Bankston,

Sarah A. Milgrom,

David Boyce-Fappiano,

Hun Ju Lee,

Ranjit Nair,

Raphaël Steiner,

Paolo Strati,

Sairah Ahmed,

Swaminathan P. Iyer,

Jason R. Westin,

Simrit Parmar,

Maria Alma Rodriguez,

Loretta J. Nastoupil,

Sattva S. Neelapu,

Christopher R. Flowers,

Bouthaina S. Dabaja

Publication year - 2020

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2020.13935

Subject(s) - abvd , medicine , dacarbazine , vinblastine , radiation therapy , positron emission tomography , stage (stratigraphy) , bleomycin , common terminology criteria for adverse events , nuclear medicine , oncology , vincristine , chemotherapy , cyclophosphamide , paleontology , biology

Key Points Question What are the radiation doses to normal tissues for patients with favorable Hodgkin lymphoma treated with modern involved-site radiation therapy? Findings This case series study included 42 patients with early-stage favorable Hodgkin lymphoma who were treated with combined modality therapy. The mean heart dose was less than 5 Gy in all patients, and the mean breast dose was 1 Gy or less in all 18 women. Meaning In this study, combined modality therapy for favorable Hodgkin lymphoma with contemporary radiation therapy delivered low radiation doses to organs at risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research